04030nam 22005055 450 991025387450332120200704092502.03-319-27935-110.1007/978-3-319-27935-0(CKB)3710000000734925(EBL)4573582(DE-He213)978-3-319-27935-0(MiAaPQ)EBC4573582(PPN)194375773(EXLCZ)99371000000073492520160629d2016 u| 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierAdvances in Microbiology, Infectious Diseases and Public Health Volume 2 /edited by Gianfranco Donelli1st ed. 2016.Cham :Springer International Publishing :Imprint: Springer,2016.1 online resource (135 p.)Advances in Microbiology, Infectious Diseases and Public Health,2365-2675 ;901Includes index.3-319-27934-3 Overview of the antimicrobial activity of 19 essential oils -- Refractory Trichophyton rubrum infections in Turin, Italy: a problem still present -- Antioxidant hydroxytyrosol-based polyacrylate with antimicrobial and antiadhesive activity versus Staphylococcus epidermidis -- The role of human Herpesvirus 8 in diabetes mellitus type 2: state of the art and a medical hypothesis -- Prevalence of Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae based on data collected by a network of clinical microbiology laboratories, in Italy -- β-defensins: work in progress -- Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy -- Carbapenem-resistant Klebsiella pneumoniae: results of a laboratory surveillance program in an Italian General Hospital (August 2014-January 2015) -- A snapshot of drug-resistant M. tuberculosis strains in Croatia -- Quorum quenching strategy targeting gram-positive pathogenic bacteria.This Series will provide microbiologists, hygienists, epidemiologists and infectious diseases specialists with well-chosen contributed volumes containing updated information in the areas of basic and applied microbiology involving relevant issues for public health, including bacterial, fungal and parasitic infections, zoonoses and anthropozoonoses, environmental and food microbiology. The increasing threat of the multidrug-resistant microorganisms and the related host immune response, the new strategies for the treatment of biofilm-based, acute and chronic microbial infections, as well as the development of new vaccines and more efficacious antimicrobial drugs to prevent and treat human and animal infections will be also reviewed in this series in the light of the most recent achievements in these fields. Special attention will be devoted to the fast diffusion worldwide of the new findings of the most advanced translational researches carried out in the different fields of microbiological sciences, with the aim to promote a prompt validation and transfer at clinical level of the most promising experimental results.Advances in Microbiology, Infectious Diseases and Public Health,2365-2675 ;901MicrobiologyMedical microbiologyMicrobiologyhttps://scigraph.springernature.com/ontologies/product-market-codes/L23004Medical Microbiologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B16003Microbiology.Medical microbiology.Microbiology.Medical Microbiology.570Donelli Gianfrancoedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910253874503321Advances in microbiology, infectious diseases and public health1901317UNINA